F7Y Stock Overview
Engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Gaush Meditech Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.22 |
| 52 Week High | HK$4.48 |
| 52 Week Low | HK$1.01 |
| Beta | 0 |
| 11 Month Change | 18.45% |
| 3 Month Change | 6.09% |
| 1 Year Change | -72.15% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -75.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| F7Y | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -6.2% | -2.5% | -1.3% |
| 1Y | -72.1% | -8.4% | 7.4% |
Return vs Industry: F7Y underperformed the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: F7Y underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| F7Y volatility | |
|---|---|
| F7Y Average Weekly Movement | 12.4% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: F7Y's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: F7Y's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 872 | Xinwei Liu | www.gaush.com |
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprises of proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd.
Gaush Meditech Ltd Fundamentals Summary
| F7Y fundamental statistics | |
|---|---|
| Market cap | €185.63m |
| Earnings (TTM) | €11.96m |
| Revenue (TTM) | €177.62m |
15.5x
P/E Ratio1.0x
P/S RatioIs F7Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| F7Y income statement (TTM) | |
|---|---|
| Revenue | CN¥1.35b |
| Cost of Revenue | CN¥720.22m |
| Gross Profit | CN¥627.35m |
| Other Expenses | CN¥536.65m |
| Earnings | CN¥90.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 46.55% |
| Net Profit Margin | 6.73% |
| Debt/Equity Ratio | 36.5% |
How did F7Y perform over the long term?
See historical performance and comparison